Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G3SZ
|
||||
Former ID |
DNC011369
|
||||
Drug Name |
ALTENUSIN
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531262] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H14O6
|
||||
Canonical SMILES |
CC1=CC(=C(C=C1C2=CC(=CC(=C2C(=O)O)O)OC)O)O
|
||||
InChI |
1S/C15H14O6/c1-7-3-11(16)12(17)6-9(7)10-4-8(21-2)5-13(18)14(10)15(19)20/h3-6,16-18H,1-2H3,(H,19,20)
|
||||
InChIKey |
ADPBTBPPIIKLEH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Induced myeloid leukemia cell differentiation protein Mcl-1 | Target Info | Inhibitor | [531262] | |
KEGG Pathway | PI3K-Akt signaling pathway | ||||
MicroRNAs in cancer | |||||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Apoptosis signaling pathway | ||||
CCKR signaling map ST | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
Direct p53 effectors | |||||
IL6-mediated signaling events | |||||
HIF-1-alpha transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.